Omega Healthcare Investors’ (OHI) “Buy” Rating Reiterated at Bank of America

Share on StockTwits

Omega Healthcare Investors (NYSE:OHI)‘s stock had its “buy” rating reaffirmed by equities research analysts at Bank of America in a report released on Monday, MarketBeat Ratings reports. They currently have a $44.50 target price on the real estate investment trust’s stock. Bank of America‘s target price would indicate a potential upside of 2.51% from the company’s current price.

Other research analysts also recently issued research reports about the company. Wells Fargo & Co raised their target price on Omega Healthcare Investors from $36.00 to $40.00 and gave the stock a “market perform” rating in a research note on Friday, August 23rd. Berenberg Bank started coverage on Omega Healthcare Investors in a research note on Thursday, September 12th. They issued a “buy” rating and a $47.00 target price for the company. Zacks Investment Research downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, August 21st. Finally, Raymond James raised their target price on Omega Healthcare Investors from $42.00 to $44.00 and gave the stock a “strong-buy” rating in a research note on Thursday, September 12th. Six equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $41.10.

OHI stock opened at $43.41 on Monday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 2.78 and a current ratio of 2.78. The company has a market capitalization of $9.42 billion, a price-to-earnings ratio of 14.28, a PEG ratio of 5.63 and a beta of 0.34. Omega Healthcare Investors has a fifty-two week low of $32.14 and a fifty-two week high of $43.63. The stock has a fifty day moving average of $41.46 and a 200-day moving average of $38.10.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.73 by ($0.39). The firm had revenue of $191.81 million for the quarter, compared to the consensus estimate of $190.46 million. Omega Healthcare Investors had a return on equity of 6.79% and a net margin of 29.38%. The firm’s revenue was down .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.75 EPS. Equities analysts predict that Omega Healthcare Investors will post 2.96 EPS for the current year.

In other news, CFO Robert O. Stephenson sold 8,000 shares of Omega Healthcare Investors stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $40.00, for a total transaction of $320,000.00. Following the completion of the sale, the chief financial officer now owns 210,130 shares in the company, valued at approximately $8,405,200. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 10,000 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $39.00, for a total value of $390,000.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,500 shares of company stock valued at $1,822,300. 1.16% of the stock is owned by corporate insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Omega Healthcare Investors by 5.6% during the 2nd quarter. Vanguard Group Inc. now owns 31,995,715 shares of the real estate investment trust’s stock valued at $1,175,842,000 after acquiring an additional 1,686,492 shares during the last quarter. BlackRock Inc. boosted its position in shares of Omega Healthcare Investors by 2.5% during the 2nd quarter. BlackRock Inc. now owns 24,907,576 shares of the real estate investment trust’s stock valued at $915,351,000 after acquiring an additional 600,319 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Omega Healthcare Investors by 2.0% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,048,815 shares of the real estate investment trust’s stock valued at $185,543,000 after acquiring an additional 98,805 shares during the last quarter. Invesco Ltd. boosted its position in shares of Omega Healthcare Investors by 19.0% during the 2nd quarter. Invesco Ltd. now owns 3,204,955 shares of the real estate investment trust’s stock valued at $117,781,000 after acquiring an additional 512,093 shares during the last quarter. Finally, Nuveen Asset Management LLC boosted its position in shares of Omega Healthcare Investors by 225.1% during the 2nd quarter. Nuveen Asset Management LLC now owns 2,751,329 shares of the real estate investment trust’s stock valued at $101,111,000 after acquiring an additional 1,904,949 shares during the last quarter. Hedge funds and other institutional investors own 69.28% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Further Reading: What is the formula for calculating total return?

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Expedia Group Inc  Receives Consensus Recommendation of “Hold” from Brokerages
Expedia Group Inc Receives Consensus Recommendation of “Hold” from Brokerages
Brokerages Set Foot Locker, Inc.  Target Price at $57.05
Brokerages Set Foot Locker, Inc. Target Price at $57.05
Celer Network Price Reaches $0.0046
Celer Network Price Reaches $0.0046
Zacks Investment Research Lowers Front Yard Residential  to Sell
Zacks Investment Research Lowers Front Yard Residential to Sell
Morgan Stanley Boosts Pioneer Natural Resources  Price Target to $174.00
Morgan Stanley Boosts Pioneer Natural Resources Price Target to $174.00
Linde’s  Neutral Rating Reiterated at Nord/LB
Linde’s Neutral Rating Reiterated at Nord/LB


 
© 2006-2019 Zolmax.